MedPath

Intensive Blood Pressure Control Shows Net Benefits for Seniors in SPRINT Trial Analysis

5 months ago2 min read

Key Insights

  • New analysis of SPRINT trial reveals 85% of seniors benefited from aggressive blood pressure management targeting 120 mmHg systolic, despite potential risks.

  • Contrary to previous concerns, elderly and frail patients with multiple medications showed greater absolute benefits in cardiovascular health and mortality reduction from intensive treatment.

  • Study findings challenge conventional medical wisdom, suggesting age, frailty, and polypharmacy should not prevent aggressive blood pressure management in older adults.

A comprehensive analysis of the Systolic Blood Pressure Intervention Trial (SPRINT) has demonstrated that aggressive blood pressure control provides substantial net benefits for older adults, challenging existing treatment paradigms for senior patients.
The study, led by Dr. Simon Ascher from the University of California-Davis, examined data from over 5,100 participants aged 65 and older, comparing outcomes between those receiving intensive treatment targeting systolic blood pressure of 120 mmHg versus the standard target of 140 mmHg.

Key Findings and Clinical Impact

The analysis revealed that approximately 85% of senior participants experienced positive net benefits from tight blood pressure control. These benefits, including reduced cardiovascular disease risk and lower mortality rates, outweighed potential adverse effects such as kidney complications or hypotension.
Particularly noteworthy was the finding that elderly patients, including those considered frail or managing multiple medications, derived even greater absolute benefits from intensive treatment, despite experiencing some treatment-related complications.

Current Treatment Landscape

The findings are especially significant given the current state of blood pressure management in the United States. Less than half of Americans aged 65 and older with diagnosed hypertension achieve adequate control, defined as blood pressure below 130/80 mmHg.
Since 2017, when initial SPRINT results led to revised guidelines, blood pressure readings above 130 mmHg systolic have been classified as hypertensive, lowered from the previous threshold of 140 mmHg. Normal blood pressure remains defined as less than 120 mmHg systolic, with readings between 120-130 mmHg considered elevated.

Challenging Traditional Treatment Approaches

The research team's findings directly challenge long-held clinical hesitations about aggressive blood pressure management in older adults. "Our findings suggest that, contrary to conventional wisdom, factors such as age, frailty, or polypharmacy should not be viewed as barriers to intensive BP lowering," the researchers emphasized.

Clinical Practice Implications

These results carry significant implications for clinical practice, particularly regarding the treatment of traditionally undertreated populations. The study suggests that healthcare providers should reconsider conservative approaches to blood pressure management in elderly patients, even those with complex medical profiles.
The findings, published in the Journal of the American Geriatrics Society, provide strong evidence supporting more aggressive blood pressure management strategies in older adults, potentially leading to improved cardiovascular outcomes and reduced mortality rates in this vulnerable population.
Subscribe Icon

Stay Updated with Our Daily Newsletter

Get the latest pharmaceutical insights, research highlights, and industry updates delivered to your inbox every day.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.